AMBER BERRY: Open Payments
NPI 1821426487 · WETHERSFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$365 in 18 payments from 15 companies in 2025. Trend: 2023 $165 · 2024 $169 · 2025 $365
Food & beverage: $365
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $68 |
| Amneal Pharmaceuticals LLC | 2 | $46 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Eisai Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
| Viatris Specialty LLC | 1 | $19 |
| Corcept Therapeutics | 1 | $17 |
Products named: BREZTRI, UNITHROID, AREXVY, XIFAXAN, JARDIANCE, Leqembi, MOUNJARO, FARXIGA.
Industry payments across CT — which companies pay providers there.
